Wu XH - Search Results

1

Three vascular endothelial growth factor polymorphisms (-460C>T, -2578C>A, 1612G>A) with cancer risk: a meta-analysis based on 30 case-control studies.

Hong TT, Cai DY, Wu XH, Hua D. Hong TT, et al. Among authors: wu xh. Cancer Invest. 2011 Aug;29(7):472-7. doi: 10.3109/07357907.2011.597811. Cancer Invest. 2011. PMID: 21740084

2

Polymorphism of vascular endothelial growth factor -1154G>A (rs1570360) with cancer risk: a meta-analysis of 16 case-control studies.

Hong TT, Zhang RX, Wu XH, Hua D. Hong TT, et al. Among authors: wu xh. Mol Biol Rep. 2012 May;39(5):5283-9. doi: 10.1007/s11033-011-1326-9. Epub 2011 Dec 14. Mol Biol Rep. 2012. PMID: 22167330

3

Preoperative serum C-reactive protein levels and early breast cancer by BMI and menopausal status.

Hong T, Liu A, Cai D, Zhang Y, Hua D, Hang X, Wu X. Hong T, et al. Cancer Invest. 2013 May;31(4):279-85. doi: 10.3109/07357907.2013.789898. Cancer Invest. 2013. PMID: 23627410

4

Prognostic significance of serum aspartic transaminase in diffuse large B-cell lymphoma.

Lu TX, Wu S, Cai DY, Hong TT, Zhang Y, Gao HQ, Hua HY, Wu XH. Lu TX, et al. Among authors: wu xh, wu s. BMC Cancer. 2019 Jun 8;19(1):553. doi: 10.1186/s12885-019-5758-2. BMC Cancer. 2019. PMID: 31176361 Free PMC article.

5

PEA3 activates VEGF transcription in T47D and SKBR3 breast cancer cells.

Hua D, Chen B, Bai M, Yu H, Wu X, Jin W. Hua D, et al. Acta Biochim Biophys Sin (Shanghai). 2009 Jan;41(1):63-8. doi: 10.1093/abbs/gmn007. Acta Biochim Biophys Sin (Shanghai). 2009. PMID: 19129951 Free article.

6

Second-line epidermal growth factor receptor inhibitors followed by third-line pemetrexed or the reverse sequence: a retrospective analysis of 83 Chinese patients with advanced lung adenocarcinoma.

Hong T, Zhang R, Cai D, Wu X, Hua D. Hong T, et al. J Cancer Res Clin Oncol. 2012 Feb;138(2):285-91. doi: 10.1007/s00432-011-1084-z. Epub 2011 Nov 25. J Cancer Res Clin Oncol. 2012. PMID: 22116317

7

A novel systematic inflammation related index is prognostic in curatively resected non-metastatic colorectal cancer.

Hong T, Shen D, Chen X, Cai D, Wu X, Hua D. Hong T, et al. Am J Surg. 2018 Sep;216(3):450-457. doi: 10.1016/j.amjsurg.2017.07.021. Epub 2017 Jul 19. Am J Surg. 2018. PMID: 28743381

8

Development and validation of a nomogram to predict survival after curative resection of nonmetastatic colorectal cancer.

Hong T, Cai D, Jin L, Zhang Y, Lu T, Hua D, Wu X. Hong T, et al. Cancer Med. 2020 Jun;9(12):4126-4136. doi: 10.1002/cam4.3010. Epub 2020 Apr 21. Cancer Med. 2020. PMID: 32314876 Free PMC article.

9

[Comparison of the efficacy of second line EGFR TKIs followed by third line pemetrexed or the reverse sequence in the treatment of advanced lung adenocarcinoma].

Zhang RX, Cai DY, Hong TT, Wu XH, Hua D. Zhang RX, et al. Among authors: wu xh. Zhonghua Zhong Liu Za Zhi. 2012 Feb;34(2):147-51. doi: 10.3760/cma.j.issn.0253-3766.2012.02.015. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 22780936 Chinese.

10

[Efficacy and safety of docetaxol, pemetrexed and EGFR-TKIs as second-line treatment for patients with advanced non-small-cell lung cancer].

Zhang RX, Cai DY, Wu XH, Hua D. Zhang RX, et al. Among authors: wu xh. Zhonghua Zhong Liu Za Zhi. 2012 Nov;34(11):869-72. doi: 10.3760/cma.j.issn.0253-3766.2012.11.016. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 23291140 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

851 results

Search Page

Filters